ConductScience.org, home

Paper36326

Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats.

Das KM and 3 others. Gastroenterology, 1979. Cited by 63 papers, by iCite.

Cite this record

ConductScience Library. Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats. Papers, record 36326. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36326

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats.
PubMed
Journal
Gastroenterology
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
63
iCite
Relative citation ratio, by iCite
3.01
iCite
Revised in PubMed
2013-11-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Das KMK M
2Chowdhury JRJ R
3Zapp BB
4Fara JWJ W

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Crohn DiseaseMajor topic
Intestinal AbsorptionMajor topic
LiverMajor topic
SulfasalazineMajor topic
Animals
Bile
Cats
Humans
Ileostomy
Male
Oxidoreductases
Physiology, Comparative
Rats

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.

PMIDTitleJournalYearIn PapersSource
42582612RUCAM-ascertained immunology and autoimmunity specifics of six idiosyncratic drug-induced liver injury types with refined classification: their individual complex molecular interplay.Front Immunol2026https://conductscience.org/library/papers/42582612PubMed
41948819Translational Modeling of Gut Microbiome-Mediated Drug Metabolism: A Case Example of Sulfasalazine.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/41948819PubMed
41096839Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity.Int J Mol Sci2025https://conductscience.org/library/papers/41096839PubMed
37047633Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations.Int J Mol Sci2023https://conductscience.org/library/papers/37047633PubMed
33987428Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.Ann Transl Med2021https://conductscience.org/library/papers/33987428PubMed
27571936Circulating intestine-derived exosomal miR-328 in plasma, a possible biomarker for estimating BCRP function in the human intestines.Sci Rep2016https://conductscience.org/library/papers/27571936PubMed
25872459Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene.Br J Clin Pharmacol2015https://conductscience.org/library/papers/25872459PubMed
25380981
Evaluation of the usefulness of breast cancer resistance protein (BCRP) knockout mice and BCRP inhibitor-treated monkeys to estimate the clinical impact of BCRP modulation on the pharmacokinetics of BCRP substrates.
Pharm Res2015https://conductscience.org/library/papers/25380981PubMed
7640156Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine.Br J Clin Pharmacol1995https://conductscience.org/library/papers/7640156PubMed
6661362Kinetics of 5-aminosalicylic acid after jejunal instillation in man.Br J Clin Pharmacol1983https://conductscience.org/library/papers/6661362PubMed
3319462Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas.Dig Dis Sci1987https://conductscience.org/library/papers/3319462PubMed
3207553Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3207553PubMed
2882965Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.Dig Dis Sci1987https://conductscience.org/library/papers/2882965PubMed
28778845-Aminosalicylic acid in patients with an ileo-rectal anastomosis. A comparison of the fate of sulfasalazine and Pentasa.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/2877884PubMed
2877850Pharmacological and biochemical actions of sulphasalazine.Drugs1986https://conductscience.org/library/papers/2877850PubMed
2864155Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.Clin Pharmacokinet1985https://conductscience.org/library/papers/2864155PubMed
2199130Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).Clin Pharmacokinet1990https://conductscience.org/library/papers/2199130PubMed
1676590Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.Drug Saf1991https://conductscience.org/library/papers/1676590PubMed
1389944Drug therapy of ulcerative colitis.Br J Clin Pharmacol1992https://conductscience.org/library/papers/1389944PubMed
1362531The three week sulphasalazine syndrome.Clin Rheumatol1992https://conductscience.org/library/papers/1362531PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36326

GET https://conductscience.org/api/papers/v1/36326/authors